학술논문

A cell-based, SARS-CoV-2 spike protein interaction assay to inform the neutralising capacity of recombinant and patient sera antibodies.
Document Type
Article
Source
Frontiers in Virology; 8/29/2023, p1-12, 12p
Subject
PROTEIN-protein interactions
SARS-CoV-2 Omicron variant
SARS-CoV-2 Delta variant
RECOMBINANT proteins
SARS-CoV-2
CO-cultures
Language
ISSN
2673818X
Abstract
Copyright of Frontiers in Virology is the property of Frontiers Media S.A. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Online Access